GE HealthCare CFO Saccaro Resigns; Newcomb Interim CFO; Q2 Results
GE HealthCare announced that James K. Saccaro will resign as Chief Financial Officer, effective August 14, 2026, to pursue an opportunity outside the medical technology industry. George Newcomb, Controller and Chief Accounting Officer, has been named interim CFO. Concurrently, the company reported preliminary unaudited second quarter 2026 results, expecting year-over-year revenue growth of 5.7% and organic revenue growth of 3.5%. Adjusted EPS is anticipated to be ahead of prior expectations, and the company reaffirmed its full-year 2026 guidance.
Key Highlights
- James K. Saccaro resigns as CFO, effective August 14, 2026.
- George Newcomb appointed interim CFO, effective August 14, 2026.
- Preliminary Q2 2026 revenue growth expected at 5.7% YoY.
- Preliminary Q2 2026 organic revenue growth expected at 3.5% YoY.
- Preliminary Q2 2026 Adjusted EPS performance ahead of prior expectation.
- Company reaffirms full-year 2026 guidance.
Price Impact
More from GEHC
GE HealthCare Appoints Lead Director & Committee Chair; Stockholders Approve Proposals
GEHC Acquires Intelerad for $2.3B; Q1 Revenue +7.4% to $5.1B; EPS $0.85
GEHC Q1 Revenue +7.4% to $5.1B; Adjusted EPS $0.99; Cuts FY26 Profit Outlook